We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002261:SZSETalkweb Information System Co.,Ltd. Analysis

Data as of 2026-06-14 - not real-time

CN¥29.81

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Talkweb is trading at CNY 29.81, well below its 20‑day (≈30.80), 50‑day (≈33.88) and 200‑day (≈34.30) moving averages, signaling a bearish price environment. The RSI sits near 44, indicating neutral momentum, while the MACD histogram is modestly positive, giving a slight bullish signal that is unlikely to overcome the broader downtrend. Valuation metrics are extreme: a trailing P/E of roughly 596 versus an industry average of 37, a forward P/E of about 157, and a DCF‑derived fair value of only CNY 3.8, all pointing to severe overvaluation. Revenue has contracted by 4.7% YoY, margins are thin (gross ~15%, operating ~9%, net ~2%) and ROE languishes at just 1.35%, underscoring weak profitability. Despite a solid cash position (≈CNY 1.13 bn) the company carries a high debt‑to‑equity ratio of over 14, raising balance‑sheet concerns. Volatility is elevated at nearly 60% over 30 days, though beta is low (~0.16), indicating limited systematic risk but high idiosyncratic swings. Regulatory scrutiny on Chinese tech firms adds an additional layer of uncertainty, while the absence of any dividend further diminishes income appeal. Overall, the stock appears significantly overvalued with limited growth traction, making it a risky holding in the near term.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Extreme P/E relative to industry
  • Bearish technical positioning below key moving averages
  • Declining revenue and thin profit margins

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong cash buffer offsetting high debt
  • Low beta limiting market‑wide volatility exposure
  • Uncertainty around Chinese tech regulatory environment

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Potential strategic shift toward AI and digital platforms
  • Persistently high valuation multiples
  • Elevated leverage and modest return on equity

Key Metrics & Analysis

Financial Health

Revenue Growth-4.70%
Profit Margin1.91%
P/E Ratio596.2
ROE1.35%
ROA0.63%
Debt/Equity14.23
P/B Ratio14.4
Op. Cash FlowCN¥476.5M
Free Cash FlowCN¥307.5M
Industry P/E36.8

Technical Analysis

TrendBearish
RSI44.3
SupportCN¥26.65
ResistanceCN¥34.69
MA 20CN¥30.80
MA 50CN¥33.88
MA 200CN¥34.30
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair ValueCN¥3.82
GradeOvervalued
TypeValue

Risk Assessment

Beta0.16
Volatility59.40%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.